FI923491A - Nya drivgaser och deras anvaendning i farmaceutiska preparat. - Google Patents

Nya drivgaser och deras anvaendning i farmaceutiska preparat. Download PDF

Info

Publication number
FI923491A
FI923491A FI923491A FI923491A FI923491A FI 923491 A FI923491 A FI 923491A FI 923491 A FI923491 A FI 923491A FI 923491 A FI923491 A FI 923491A FI 923491 A FI923491 A FI 923491A
Authority
FI
Finland
Prior art keywords
pharmaceutical
preparation
pharmaceutical preparation
tgh
dme
Prior art date
Application number
FI923491A
Other languages
English (en)
Other versions
FI923491A0 (fi
FI103348B1 (fi
FI103348B (fi
Inventor
Hans-Hermann Weil
Ottfried Daab
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI923491(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI923491A0 publication Critical patent/FI923491A0/fi
Publication of FI923491A publication Critical patent/FI923491A/fi
Application granted granted Critical
Publication of FI103348B1 publication Critical patent/FI103348B1/fi
Publication of FI103348B publication Critical patent/FI103348B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/30Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI923491A 1990-02-03 1992-08-03 Menetelmä lääkeainesuspension valmistamiseksi FI103348B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4003270A DE4003270A1 (de) 1990-02-03 1990-02-03 Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4003270 1990-02-03
PCT/EP1991/000178 WO1991011496A1 (de) 1990-02-03 1991-01-31 Neue treibgase und ihre verwendung in arzneimittelzubereitungen
EP9100178 1991-01-31

Publications (4)

Publication Number Publication Date
FI923491A0 FI923491A0 (fi) 1992-08-03
FI923491A true FI923491A (fi) 1992-08-03
FI103348B1 FI103348B1 (fi) 1999-06-15
FI103348B FI103348B (fi) 1999-06-15

Family

ID=6399399

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923491A FI103348B (fi) 1990-02-03 1992-08-03 Menetelmä lääkeainesuspension valmistamiseksi

Country Status (26)

Country Link
US (7) US6419899B1 (fi)
EP (1) EP0513099B1 (fi)
JP (1) JP3497162B2 (fi)
KR (1) KR920703034A (fi)
AT (1) ATE185587T1 (fi)
AU (1) AU656129B2 (fi)
CA (1) CA2075060C (fi)
CZ (1) CZ285209B6 (fi)
DE (2) DE4003270A1 (fi)
DK (1) DK0513099T3 (fi)
ES (1) ES2139574T3 (fi)
FI (1) FI103348B (fi)
GR (1) GR3032176T3 (fi)
HK (1) HK1010737A1 (fi)
HR (1) HRP940737B1 (fi)
HU (1) HU218664B (fi)
IL (1) IL97024A0 (fi)
NO (1) NO302420B1 (fi)
NZ (1) NZ236974A (fi)
PT (1) PT96635B (fi)
RU (1) RU2118170C1 (fi)
SI (1) SI9110155B (fi)
SK (1) SK281440B6 (fi)
WO (1) WO1991011496A1 (fi)
YU (1) YU48509B (fi)
ZA (1) ZA91756B (fi)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
DE69105212T2 (de) * 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
NZ243061A (en) 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
US5221492A (en) * 1991-08-23 1993-06-22 E. I. Du Pont De Nemours And Company Azeotropic mixture of perfluoropropane and dimethyl ether
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
AU3936293A (en) * 1992-03-26 1993-10-21 Great Lakes Chemical Corporation Azeotrope-like compositions of 1,1,1,2,3,3,3-heptafluoropropane and 1,1-difluoroethane
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6135628A (en) * 1995-10-13 2000-10-24 Boehringer Ingelheim Pharmceuticals, Inc. Method and apparatus for homogenizing aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
DE19652790A1 (de) * 1996-12-18 1998-06-25 Hermes Fabrik Pharm Praeparate Pharmazeutische Zubereitungen
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7273603B2 (en) 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
JP5209963B2 (ja) * 2004-07-02 2013-06-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 噴霧剤としてtg227ea又はtg134aを含有するエアロゾル懸濁製剤
WO2006114379A1 (de) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
EP2282418A3 (en) 2009-06-23 2011-03-09 Alcatel Lucent A station comprising at least two transmit antennas, and a method of transmitting therefrom
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2490764A (en) * 1945-07-04 1949-12-13 Kinetic Chemicals Inc Fluorinated organic compounds
BE555319A (fi) * 1956-03-21 1900-01-01
BE556587A (fi) 1957-01-31 1957-04-11
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
NL289785A (fi) * 1962-11-29
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
US3369913A (en) * 1967-03-20 1968-02-20 Union Carbide Corp Self-propelling food mixture
DE1719443B2 (de) 1967-10-07 1973-04-05 Suspensions-aerosole und verfahren zu ihrer herstellung
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
IL51314A (en) 1976-01-30 1980-03-31 Fisons Ltd Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4174795A (en) * 1977-02-14 1979-11-20 Bohm Leslie E Pannier mounting arrangement for cycles
GB2001334B (en) 1977-07-19 1982-03-03 Fisons Ltd Pressurised aerosol formulation
CA1136547A (en) 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
JPS55131096A (en) 1979-03-30 1980-10-11 Daikin Ind Ltd Working fluid for rankine cycle
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
EP0044227B1 (en) * 1980-07-16 1983-08-24 Glaxo Group Limited 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
GB8432063D0 (en) 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
GB8501015D0 (en) 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
DE3735467A1 (de) 1987-10-20 1989-05-03 Bayer Ag Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3903336A1 (de) 1989-02-04 1990-08-09 Bayer Ag Verwendung von c(pfeil abwaerts)3(pfeil abwaerts)- bis c(pfeil abwaerts)5(pfeil abwaerts)-polyfluoralkanen als treibgase
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2642738B2 (ja) 1989-04-13 1997-08-20 ライオン株式会社 人体塗布用エアゾール製品
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
NZ243061A (en) 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
US6503482B1 (en) 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
DE59206234D1 (de) 1991-12-31 1996-06-13 Hoechst Ag Medizinische Aerosolformulierung
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
KR19980703850A (ko) * 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
AU718967B2 (en) 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation

Also Published As

Publication number Publication date
PT96635B (pt) 1998-07-31
CA2075060C (en) 2001-01-02
KR920703034A (ko) 1992-12-17
FI923491A0 (fi) 1992-08-03
US6419899B1 (en) 2002-07-16
RU2118170C1 (ru) 1998-08-27
FI103348B1 (fi) 1999-06-15
JP3497162B2 (ja) 2004-02-16
ZA91756B (en) 1992-10-28
CA2075060A1 (en) 1991-08-04
NO923040D0 (no) 1992-07-31
DK0513099T3 (da) 2000-04-10
US20070065370A1 (en) 2007-03-22
SI9110155A (sl) 1998-04-30
AU656129B2 (en) 1995-01-27
US7160538B2 (en) 2007-01-09
DE59109161D1 (de) 1999-11-18
NO302420B1 (no) 1998-03-02
DE4003270A1 (de) 1991-08-08
AU7211691A (en) 1991-08-21
HUT62455A (en) 1993-05-28
HRP940737B1 (en) 2000-10-31
YU48509B (sh) 1998-09-18
SK281440B6 (sk) 2001-03-12
CS9100265A2 (en) 1991-09-15
WO1991011496A1 (de) 1991-08-08
JPH05504350A (ja) 1993-07-08
US20110014134A1 (en) 2011-01-20
US20050031548A1 (en) 2005-02-10
NZ236974A (en) 1993-07-27
EP0513099B1 (de) 1999-10-13
PT96635A (pt) 1991-10-31
FI103348B (fi) 1999-06-15
CZ285209B6 (cs) 1999-06-16
ES2139574T3 (es) 2000-02-16
HU218664B (hu) 2000-10-28
NO923040L (no) 1992-07-31
HU9202508D0 (en) 1992-10-28
YU15591A (sh) 1994-01-20
US20020071812A1 (en) 2002-06-13
HK1010737A1 (en) 1999-06-25
US20040028618A1 (en) 2004-02-12
ATE185587T1 (de) 1999-10-15
US20090104127A1 (en) 2009-04-23
HRP940737A2 (en) 1997-06-30
GR3032176T3 (en) 2000-04-27
EP0513099A1 (de) 1992-11-19
IL97024A0 (en) 1992-03-29
SI9110155B (sl) 1999-06-30

Similar Documents

Publication Publication Date Title
FI923491A0 (fi) Nya drivgaser och deras anvaendning i farmaceutiska preparat.
FI863730A (fi) Laekemedel innehaollande klorfluorkolvaete-aerosoldrivmedelkompositioner.
EP0213527A3 (en) Foamable compositions and processes for use thereof foamable compositions and processes for use thereof
DE69105212D1 (de) Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
GB1536813A (en) Propellant compositions for aerosols
DK265689D0 (da) Anvendelse af 1,1,1,4,4,4-hexafluorbutan som driv- og isoleringsgas til fremstilling af kunststofskumstoffer
EP0333071A3 (en) Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use
DK0439846T4 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til deres fremstilling samt deres anvendelse til depotpræparater med regule
SE8902186L (sv) Nya polypeptider och deras anvaendning
EP0626421A4 (en) POROGENIC AGENT COMPOSITION, PRODUCTION OF FOAM USING THE SAME, AND FOAM THUS PRODUCED.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
AR229954A1 (es) Procedimiento de preparacion de 1,2-bis(nicotinamido)propano o sus sales farmaceuticamente adecuadas
NO891926D0 (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
FR2703262B1 (fr) Mélanges gazeux.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
FI932332A0 (fi) Nya pyridobenzoindolderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat
SE8004976L (sv) Nya 4-fenyl-4,5,6,7-tetrahydro-pyrrolo(2,3-c)pyridiner, forfarande for framstellning derav och farmaceutiska kompositioner
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
MASTUMOTO et al. Planning and Transportation Engineering Sections, Dept. of Civil Engineering, Nagaoka University Technology
NO902329L (no) Antiinflammatoriske og analgetiske forbindelser, beslektede preparater og fremgangsmaater for fremstilling og anvendelse derav.
NO913298D0 (no) Terapeutisk aerosolpreparater.
ATA246588A (de) Atmosphärischer vormisch-gasbrenner
NO902892D0 (no) Fremgangsmaate for fremstilling av polyetylenvoks ved gassfase-polymerisasjon.
DK36290D0 (da) Nitroolefiner, praeparater indeholdende dem samt anvendelse af dem til fremstilling af farmaceutiske praeparater